Increased production of tumour necrosis factor by peripheral blood leukocytes in patients with recurrent oral aphthous ulceration
- PMID: 1593490
- DOI: 10.1111/j.1600-0714.1992.tb00963.x
Increased production of tumour necrosis factor by peripheral blood leukocytes in patients with recurrent oral aphthous ulceration
Abstract
Much evidence suggests that recurrent oral aphthous ulceration (RAU) is an immunologically mediated disease. Tumour necrosis factor has multiple biologic properties, some of which may be relevant to the pathogenesis of RAU. This study has assessed its production by peripheral blood leukocytes from aphthous patients in active and remission phases of disease and from patients with nonaphthous ulceration (diseased controls). Each ulcer patient was studied in parallel with a matched healthy control volunteer. A bioassay against the standard mouse fibrosarcoma line, L929, was used to assess the levels of tumour necrosis factor-alpha (TNF). Significantly greater amounts of TNF were released from unstimulated monocyte-enriched and monocyte-depleted leukocyte fractions in active RAU compared with those from healthy control donors, suggesting that this cytokine may be associated with RAU.
Similar articles
-
The in vitro cytotoxic effect of leukocytes from patients with recurrent aphthous ulceration upon mouse 3T3 fibroblasts.J Oral Pathol. 1988 Sep;17(8):421-5. doi: 10.1111/j.1600-0714.1988.tb01308.x. J Oral Pathol. 1988. PMID: 3146629
-
Immunolocalization of tumor necrosis factor-alpha expressing cells in recurrent aphthous ulcer lesions (RAU).J Oral Pathol Med. 2000 Jan;29(1):19-25. doi: 10.1034/j.1600-0714.2000.290104.x. J Oral Pathol Med. 2000. PMID: 10678712
-
Toll-like receptor activity in recurrent aphthous ulceration.J Oral Pathol Med. 2009 Mar;38(3):289-98. doi: 10.1111/j.1600-0714.2008.00743.x. J Oral Pathol Med. 2009. PMID: 19267841
-
Oral ulceration in HIV infection: investigation and pathogenesis.Oral Dis. 1997 May;3 Suppl 1:S190-3. doi: 10.1111/j.1601-0825.1997.tb00358.x. Oral Dis. 1997. PMID: 9456687 Review.
-
Efficacy of tumour necrosis factor-α antagonists in aphthous ulceration: review of published individual patient data.J Eur Acad Dermatol Venereol. 2012 Feb;26(2):231-5. doi: 10.1111/j.1468-3083.2011.04041.x. Epub 2011 Mar 24. J Eur Acad Dermatol Venereol. 2012. PMID: 22280510 Review.
Cited by
-
Revisited and innovative perspectives of oral ulcer: from biological specificity to local treatment.Front Bioeng Biotechnol. 2024 Feb 22;12:1335377. doi: 10.3389/fbioe.2024.1335377. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 38456005 Free PMC article. Review.
-
IL-10 and TGF-β1 gene polymorphisms in Greek patients with recurrent aphthous stomatitis.Med Oral Patol Oral Cir Bucal. 2022 Sep 1;27(5):e426-e433. doi: 10.4317/medoral.25352. Med Oral Patol Oral Cir Bucal. 2022. PMID: 35660731 Free PMC article.
-
Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet's Disease.Front Immunol. 2021 Dec 22;12:724900. doi: 10.3389/fimmu.2021.724900. eCollection 2021. Front Immunol. 2021. PMID: 35003055 Free PMC article.
-
Treatment of recurrent aphthous stomatitis (RAS; aphthae; canker sores) with a barrier forming mouth rinse or topical gel formulation containing hyaluronic acid: a retrospective clinical study.BMC Oral Health. 2019 Jul 16;19(1):153. doi: 10.1186/s12903-019-0850-1. BMC Oral Health. 2019. PMID: 31311529 Free PMC article.
-
Salivary levels of TNF-α in patients with recurrent aphthous stomatitis: A cross-sectional study.J Dent Res Dent Clin Dent Prospects. 2018 Winter;12(1):45-48. doi: 10.15171/joddd.2018.007. Epub 2018 Mar 14. J Dent Res Dent Clin Dent Prospects. 2018. PMID: 29732020 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
